Cheryl Gault, Chief Operating Officer at Rapport Therapeutics, Inc. (RAPP), sold 2,014 shares at $28.93 ($58K) on 2026-03-05, disclosed to the SEC on 2026-03-09.
Open-market sale of $58k RAPP by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RAPP | SELL | 2025-12-01 | $151K | — | Filing → |
| RAPP | SELL | 2025-09-10 | $192K | — | Filing → |